0000899243-22-027733.txt : 20220804 0000899243-22-027733.hdr.sgml : 20220804 20220804210936 ACCESSION NUMBER: 0000899243-22-027733 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220802 FILED AS OF DATE: 20220804 DATE AS OF CHANGE: 20220804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hannan Kathy Hopinkah CENTRAL INDEX KEY: 0001767813 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40097 FILM NUMBER: 221138360 MAIL ADDRESS: STREET 1: ANNALY CAPITAL MANAGEMENT, INC. STREET 2: 1211 AVE. OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ginkgo Bioworks Holdings, Inc. CENTRAL INDEX KEY: 0001830214 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 872652913 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 27 DRYDOCK AVENUE STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (877) 442-5362 MAIL ADDRESS: STREET 1: 27 DRYDOCK AVENUE STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Soaring Eagle Acquisition Corp. DATE OF NAME CHANGE: 20210210 FORMER COMPANY: FORMER CONFORMED NAME: Spinning Eagle Acquisition Corp. DATE OF NAME CHANGE: 20201027 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-02 0 0001830214 Ginkgo Bioworks Holdings, Inc. DNA 0001767813 Hannan Kathy Hopinkah C/O GINKGO BIOWORKS HOLDINGS, INC. 27 DRYDOCK AVENUE BOSTON MA 02210 1 0 0 0 Class A Common Stock 2022-08-02 4 A 0 56986 0.00 A 61986 D Stock Option 2.03 2022-08-02 4 A 0 84216 0.00 A 2032-08-02 Class A Common Stock 84216 84216 D Stock Option 2.14 2022-08-02 4 A 0 186915 0.00 A 2032-08-02 Class A Common Stock 186915 186915 D Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock. The vesting date of the RSUs and additional stock options, and in the case of the additional stock options, the exercise date, will be the day immediately prior to the date of the next Annual Meeting of Shareholders of the Issuer occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such date. In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the option award as of the grant date is a prorated amount based on $200,000. The initial stock options shall vest and become exercisable in substantially equal installments on each of the first three anniversaries of the date of grant, such that the initial stock options shall be fully vested on the third anniversary of the date of grant, subject to the Reporting Person continuing in service as a Non-Employee Director through such date. In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the option award as of the grant date is $400,000. /s/ Karen Tepichin, Attorney-in-Fact 2022-08-04